Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535610-25-000022
Filing Date
2025-01-03
Accepted
2025-01-03 18:16:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7640
  Complete submission text file 0001535610-25-000022.txt   9478
Mailing Address 7012 FISHER ISLAND DR MIAMI BEACH FL 33109
Business Address 7012 FISHER ISLAND DR MIAMI BEACH FL 33109 646-307-4500
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Subject) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89384 | Film No.: 25508390
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)